External Beam Radiation Therapy Is Not Effective in the Treatment of Age-related Macular Degeneration
Arch Ophthalmol. 1998;116:1509-1511.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
THE AUTHORS of multiple recent publications and presentations have suggested that relatively low-dose external beam radiation therapy (EBRT) may be beneficial visually for patients with exudative-hemorrhage (wet) age-related macular degeneration (ARMD) associated with subfoveal choroidal neovascularization (CNV). In my opinion, the reported evidence is not sufficiently compelling for me to recommend this therapy. Let me explain why I believe this to be the case.
Most published information about EBRT for wet ARMD with subfoveal CNV comes from uncontrolled case series reports.1-5 Although such reports can be used as evidence that low-dose EBRT does not uniformly prevent visual worsening or progression of the macular lesion and that the macular lesion sometimes stabilizes and visual acuity sometimes stabilizes or improves (at least for a relatively short-term posttreatment interval) after EBRT, this evidence is not sufficient for inferring that EBRT is better than, the same as, or worse than the natural history of . . . [Full Text of this Article]
RELATED ARTICLE
Radiotherapy and the Treatment of Age-related Macular Degeneration; External Beam Radiation Therapy Is Effective in the Treatment of Age-related Macular Degeneration
Paul T. Finger and Usha Chakravarthy
Arch Ophthalmol. 1998;116(11):1507-1509.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration
Chiquet et al.
Br. J. Ophthalmol. 1999;83:923-928.
ABSTRACT
| FULL TEXT
|
